+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Service, Type, Source, and Research Area, End Users, and Geography

  • PDF Icon

    Report

  • 216 Pages
  • June 2021
  • Region: Global
  • The Insight Partners
  • ID: 5394026
UP TO OFF until Jun 30th 2024
High Demand in Research Drives Growth of Custom Antibody Market



According to the new research study on “Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Service, Type, Source, Research Area and End User,” the market is expected to reach US$ 833.71 million by 2028 from US$ 409.26 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the factors such as the high demand for research, growing support from governments, continuously changing disease profiles, and increasing funding activities that are widely enhancing the performance of biotechnology. However, the high cost of production hinders market growth.



Custom antibodies are widely preferred in research to differentiate antibody products. These antibodies are continuously evaluated to provide safe, accurate, and efficient products with improved quality. For instance, in January 2020, as per World Health Organization (WHO), a collaborative team of Chinese and Australian researchers has published their research for the first genome of the virus. The SARS-CoV-2 was critical for research studies, especially in the investigations about the development of vaccines against it. Thus, the virus was sequenced over 3,000 times till May 13, 2020, to make its genetic map freely available to researchers globally, which generated massive demand for custom antibodies. Small and medium-sized companies have increased their research and development investments and activities exponentially. In April 2020, the US federal government allocated US$ 3.5 billion to Biomedical Advanced Research and Development Authority (BARDA) under its Coronavirus Aid, Relief, and Economic Security (CARES) Act to support the authority’s expenses for processes such as manufacturing, production, and procurement of vaccines, therapeutics, diagnostics, and small molecule active pharmaceutical ingredients (APIs). In addition, the fund is allocated for further use, such as development, translation, and demonstration of innovations at a larger scale suitable for manufacturing. Such investments have escalated the demand for custom antibodies.



Geographically, the custom antibody market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SCAM). The North American region holds the largest market share, whereas the Asia Pacific region is the fastest-growing region. The growth factors contributing to the market’s growth in the North American region are increasing research activity and funding, quality concerns over catalog antibodies, growing antibody therapeutics and expanding drug pipeline, developing industry-academia collaborations. In the Asia Pacific, Japan is the largest market for custom antibodies. The market growth in Japan is attributed to the key driving factors such as the presence of key market players and their engagement in product developments, as the high demand in research, growing support from governments, continuously changing disease profiles, and increasing funding activities are widely intensifying the performance of biotechnology.



Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; Merck KGaA; ABCAM; GenScript; Rockland Immunochemicals, Inc; ProMab; BioLegend, Inc; Agilent Technologies, Inc; Cell Signaling Technology, Inc; are among the leading companies operating in the custom antibody market.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the custom antibody market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global custom antibody market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 The Publisher's Research Report Guidance
1.3 Market Segmentation
1.3.1 Custom Antibody Market - By Service
1.3.2 Custom Antibody Market - By Type
1.3.3 Custom Antibody Market - By Source
1.3.4 Custom Antibody Market - By Research Area
1.3.5 Custom Antibody Market - By End User
1.3.6 Custom Antibody Market - By Geography
2. Custom Antibody Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Custom Antibody Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America: PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 Asia Pacific: PEST Analysis
4.2.4 Middle East and Africa: PEST Analysis
4.2.5 South and Central America: PEST Analysis
4.3 Expert Opinion
5. Custom Antibody Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Demand in Research
5.1.2 Market Consolidations Strategies Adopted by Biotechnology Companies
5.1.3 Production and Development Services Offered by Custom Antibody Providers
5.2 Market Restraints
5.2.1 High Cost of Production
5.3 Market Opportunities
5.3.1 Proliferation of Biotechnology Industry in Developing Regions
5.4 Future Trends
5.4.1 Developments for Custom Antibodies
5.5 Impact Analysis
6. Custom Antibody Market - Global Analysis
6.1 Global Custom Antibody Marker Revenue Forecast and Analysis
6.2 Global Custom Antibody Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Custom Antibody Market Analysis - By Service
7.1 Overview
7.2 Custom Antibody Market Revenue Share, by Service (2020 and 2028)
7.3 Antibody Development
7.3.1 Overview
7.3.2 Antibody Development: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Antibody Production and Purification
7.4.1 Overview
7.4.2 Antibody Production and Purification: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
7.5 Antibody Fragmentation and Labelling
7.5.1 Overview
7.5.2 Antibody Fragmentation and Labelling: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
8. Custom Antibody Market Analysis - By Type
8.1 Overview
8.2 Custom Antibody Market Revenue Share, by Type (2020 and 2028)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Monoclonal Antibodies: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
8.4 Polyclonal Antibodies
8.4.1 Overview
8.4.2 Polyclonal Antibodies: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
8.5 Other Custom Antibodies
8.5.1 Overview
8.5.2 Other Custom Antibodies: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
9. Custom Antibody Market Analysis - By Source
9.1 Overview
9.2 Custom Antibody Market Revenue Share, By Source (2020 and 2028)
9.3 Mice
9.3.1 Overview
9.3.2 Mice: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Rabbit
9.4.1 Overview
9.4.2 Rabbit: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10. Custom Antibody Market Analysis - By Research Area
10.1 Overview
10.2 Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Immunology
10.4.1 Overview
10.4.2 Immunology: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Stem Cells
10.5.1 Overview
10.5.2 Stem Cells: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Disease
10.6.1 Overview
10.6.2 Infectious Disease: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.7 Neurobiology
10.7.1 Overview
10.7.2 Neurobiology: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.8 Cardiovascular Disease
10.8.1 Overview
10.8.2 Cardiovascular disease: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Custom Antibody Market - Revenue and Forecast to 2028 (US$ Million)
11. Custom Antibody Market Analysis - By End User
11.1 Overview
11.2 Custom Antibody Market Revenue Share, by End User (2020 and 2028)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
11.4 Academic and Research Institutes
11.4.1 Overview
11.4.2 Academic and Research Institutes: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: Custom Antibody Market- Revenue and Forecast to 2028 (US$ Million)
12. Custom Antibody Market - Geographical Analysis
12.1 North America: Custom Antibody Market Revenue and Forecast to 2028
12.1.1 Overview
12.1.2 North America: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.3 North America: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.1.4 North America: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.1.5 North America: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.1.6 North America: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.1.7 North America: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.1.8 North America: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.1.8.1 US: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.1.1 US: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.1.2 US: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.1.8.1.3 US: Custom antibody Market, by Type, 2019-2028 (USD Million)
12.1.8.1.4 US: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.1.8.1.5 US: Custom antibody Market, by Research Area, 2019-2028 (USD Million)
12.1.8.1.6 US: Custom antibody Market, by End User, 2019-2028 (USD Million)
12.1.8.2 Canada: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.2.1 Canada: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.2.2 Canada: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.1.8.2.3 Canada: Custom antibody Market, by Type, 2019-2028 (USD Million)
12.1.8.2.4 Canada: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.1.8.2.5 Canada: Custom antibody Market, by Research Area, 2019-2028 (USD Million)
12.1.8.2.6 Canada: Custom antibody Market, by End User, 2019-2028 (USD Million)
12.1.8.3 Mexico: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.3.1 Mexico: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.1.8.3.2 Mexico: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.1.8.3.3 Mexico: Custom antibody Market, by Type, 2019-2028 (USD Million)
12.1.8.3.4 Mexico: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.1.8.3.5 Mexico: Custom antibody Market, by Research Area, 2019-2028 (USD Million)
12.1.8.3.6 Mexico: Custom antibody Market, by End User, 2019-2028 (USD Million)
12.2 Europe: Custom Antibody Market
12.2.1 Overview
12.2.2 Europe: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.3 Europe: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.4 Europe: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.5 Europe: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.6 Europe: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.7 Europe: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8 Europe: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.2.8.1 UK: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.1.1 UK: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.1.2 UK: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.1.3 UK: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.1.4 UK: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.1.5 UK: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.1.6 UK: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8.2 Germany: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.2.1 Germany: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.2.2 Germany: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.2.3 Germany: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.2.4 Germany: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.2.5 Germany: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.2.6 Germany: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8.3 France: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.3.1 France: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.3.2 France: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.3.3 France: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.3.4 France: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.3.5 France: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.3.6 France: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8.4 Italy: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.4.1 Italy: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.4.2 Italy: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.4.3 Italy: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.4.4 Italy: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.4.5 Italy: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.4.6 Italy: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8.5 Spain: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.5.1 Spain: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.5.2 Spain: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.5.3 Spain: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.5.4 Spain: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.5.5 Spain: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.5.6 Spain: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.2.8.6 Rest of Europe: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.6.1 Rest of Europe: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.2.8.6.2 Rest of Europe: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.2.8.6.3 Rest of Europe: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.2.8.6.4 Rest of Europe: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.2.8.6.5 Rest of Europe: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.2.8.6.6 Rest of Europe: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3 Asia-Pacific Custom Antibody Market Revenue and Forecasts to 2028
12.3.1 Overview
12.3.2 Asia Pacific: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.3 Asia Pacific: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.4 Asia Pacific: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.5 Asia Pacific: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.6 Asia Pacific: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.7 Asia Pacific: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8 Asia Pacific: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.3.8.1 China: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.1.1 China: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.1.2 China: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.1.3 China: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.1.4 China: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.1.5 China: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.1.6 China: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8.2 Japan: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.2.1 Japan: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.2.2 Japan: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.2.3 Japan: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.2.4 Japan: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.2.5 Japan: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.2.6 Japan: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8.3 India: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.3.1 India: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.3.2 India: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.3.3 India: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.3.4 India: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.3.5 India: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.3.6 India: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8.4 South Korea: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.4.1 South Korea: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.4.2 South Korea: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.4.3 South Korea: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.4.4 South Korea: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.4.5 South Korea: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.4.6 South Korea: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8.5 Australia: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.5.1 Australia: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.5.2 Australia: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.5.3 Australia: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.5.4 Australia: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.5.5 Australia: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.5.6 Australia: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.3.8.6 Rest of Asia-Pacific: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.6.1 Rest of Asia-Pacific: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.3.8.6.2 Rest of Asia-Pacific: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.3.8.6.3 Rest of Asia-Pacific: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.3.8.6.4 Rest of Asia-Pacific: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.3.8.6.5 Rest of Asia-Pacific: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.3.8.6.6 Rest of Asia-Pacific: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.4 Middle East & Africa: Custom Antibody Market Revenue and Forecasts To 2028
12.4.1 Overview
12.4.2 Middle East and Africa: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.3 Middle East and Africa: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.4.4 Middle East and Africa: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.4.5 Middle East and Africa: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.4.6 Middle East and Africa: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.4.7 Middle East and Africa: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.4.8 Middle East and Africa: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.4.8.1 Saudi Arabia: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.1 Saudi Arabia: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.1.2 Saudi Arabia: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.4.8.1.3 Saudi Arabia: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.4.8.1.4 Saudi Arabia: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.4.8.1.5 Saudi Arabia: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.4.8.1.6 Saudi Arabia: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.4.8.2 UAE: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.1 UAE: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.2.2 UAE: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.4.8.2.3 UAE: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.4.8.2.4 UAE: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.4.8.2.5 UAE: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.4.8.2.6 UAE: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.4.8.3 South Africa: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.1 South Africa: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.3.2 South Africa: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.4.8.3.3 South Africa: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.4.8.3.4 South Africa: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.4.8.3.5 South Africa: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.4.8.3.6 South Africa: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.4.8.4 Rest of Middle East and Africa: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.4.1 Rest of Middle East and Africa: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.4.8.4.2 Rest of Middle East and Africa: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.4.8.4.3 Rest of Middle East and Africa: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.4.8.4.4 Rest of Middle East and Africa: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.4.8.4.5 Rest of Middle East and Africa: Custom Antibody Market, by Research area, 2019-2028 (USD Million)
12.4.8.4.6 Rest of Middle East and Africa: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.5 South and Central America: Custom antibody Market Revenue and Forecast to 2028
12.5.1 Overview
12.5.2 South and Central America: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.3 South and Central America: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.5.4 South and Central America: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.5.5 South and Central America: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.5.6 South and Central America: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.5.7 South and Central America: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.5.8 South and Central America: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.5.8.1 Brazil: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.1.1 Brazil: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.1.2 Brazil: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.5.8.1.3 Brazil: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.5.8.1.4 Brazil: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.5.8.1.5 Brazil: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.5.8.1.6 Brazil: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.5.8.2 Argentina: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.2.1 Argentina: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.2.2 Argentina: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.5.8.2.3 Argentina: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.5.8.2.4 Argentina: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.5.8.2.5 Argentina: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.5.8.2.6 Argentina: Custom Antibody Market, by End User, 2019-2028 (USD Million)
12.5.8.3 Rest of South and Central America: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.3.1 Rest of South and Central America: Custom Antibody Market - Revenue and Forecast to 2028 (USD Million)
12.5.8.3.2 Rest of South and Central America: Custom Antibody Market, by Service, 2019-2028 (USD Million)
12.5.8.3.3 Rest of South and Central America: Custom Antibody Market, by Type, 2019-2028 (USD Million)
12.5.8.3.4 Rest of South and Central America: Custom Antibody Market, by Source, 2019-2028 (USD Million)
12.5.8.3.5 Rest of South and Central America: Custom Antibody Market, by Research Area, 2019-2028 (USD Million)
12.5.8.3.6 Rest of South and Central America: Custom Antibody Market, by End User, 2019-2028 (USD Million)
13. Impact of COVID-19 Pandemic on Global Custom Antibody Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
13.5 South and Central America: Impact Assessment of COVID-19 Pandemic
14. Custom Antibody Market-Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Custom Antibody Market, 2020-2021
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BIO-RAD LABORATORIES INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 MERCK KGaA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ABCAM
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 GenScript
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Rockland Immunochemicals, Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 ProMab
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 BioLegend, Inc.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Agilent Technologies, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Cell Signaling Technology, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Thermo Fisher Scientific Inc
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • ABCAM
  • GenScript
  • Rockland Immunochemicals, Inc
  • ProMab
  • BioLegend, Inc
  • Agilent Technologies, Inc
  • Cell Signaling Technology, Inc

Table Information